| The alpha keto amide moiety as a privileged motif in medicinal chemistry: current insights and emerging opportunities M Robello, E Barresi, E Baglini, S Salerno, S Taliani, FD Settimo Journal of Medicinal Chemistry 64 (7), 3508-3545, 2021 | 88 | 2021 |
| An update into the medicinal chemistry of translocator protein (TSPO) ligands E Barresi, M Robello, B Costa, E Da Pozzo, E Baglini, S Salerno, ... European Journal of Medicinal Chemistry 209, 112924, 2021 | 46 | 2021 |
| Multiple Topoisomerase I (TopoI), Topoisomerase II (TopoII) and Tyrosyl-DNA Phosphodiesterase (TDP) inhibitors in the development of anticancer drugs E Baglini, S Salerno, E Barresi, M Robello, F Da Settimo, S Taliani, ... European Journal of Pharmaceutical Sciences 156, 105594, 2021 | 45 | 2021 |
| Lead optimization of 2-phenylindolylglyoxylyldipeptide murine double minute (MDM) 2/translocator protein (TSPO) dual inhibitors for the treatment of gliomas S Daniele, V La Pietra, E Barresi, S Di Maro, E Da Pozzo, M Robello, ... Journal of Medicinal Chemistry 59 (10), 4526-4538, 2016 | 29 | 2016 |
| Toward PET imaging of A2B adenosine receptors: a carbon-11 labeled triazinobenzimidazole tracer: Synthesis and imaging of a new A2B PET tracer D Petroni, C Giacomelli, S Taliani, E Barresi, M Robello, S Daniele, ... Nuclear Medicine and Biology 43 (5), 309-317, 2016 | 13 | 2016 |
| Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A1 and A2B adenosine receptor subtypes E Barresi, C Giacomelli, S Daniele, I Tonazzini, M Robello, S Salerno, ... Bioorganic & Medicinal Chemistry 26 (22), 5885-5895, 2018 | 11 | 2018 |
| Residence Time, a New parameter to Predict Neurosteroidogenic Efficacy of Translocator Protein (TSPO) Ligands: the Case Study of N,N‐Dialkyl‐2‐arylindol‐3 … B Costa, S Taliani, E Da Pozzo, E Barresi, M Robello, C Cavallini, ... ChemMedChem 12 (16), 1275-1278, 2017 | 11 | 2017 |
| Benzothiopyranoindole-and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases S Salerno, V La Pietra, M Hyeraci, S Taliani, M Robello, E Barresi, C Milite, ... European Journal of Medicinal Chemistry 165, 46-58, 2019 | 7 | 2019 |
| The structure-activity profile of mercaptobenzamides’ anti-HIV activity suggests that thermodynamics of metabolism is more important than binding affinity to the target H Nikolayevskiy, M Robello, MT Scerba, EH Pasternak, M Saha, ... European journal of medicinal chemistry 178, 818-837, 2019 | 6 | 2019 |
| Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry E Barresi, M Robello, E Baglini, V Poggetti, M Viviano, S Salerno, ... Pharmaceuticals 16 (7), 997, 2023 | 4 | 2023 |
| New antiproliferative agents derived from tricyclic 3,4‐dihydrobenzo[4,5]imidazo[1,2‐a][1,3,5]triazine scaffold: Synthesis and pharmacological effects M Robello, S Salerno, E Barresi, P Orlandi, F Vaglini, M Banchi, ... Archiv der Pharmazie 355 (11), 2200295, 2022 | 3 | 2022 |
| Covalent Modification of p53 by (E)-1-(4-Methylpiperazin-1-yl)-3-(5-nitrofuran-2-yl)prop-2-en-1-one K Brown, M Robello, AJ Perciaccante, JC Dinan, TK Maity, GC Lyons, ... ACS Pharmacology & Translational Science 7 (11), 3559-3572, 2024 | | 2024 |
| Prodrug Strategy Extends the Use of Anti-HIV Sulfanylbenzamides for Application In Vivo M Robello, H Nikolayevskiy, MT Scerba, RA Nahui Palomino, V Mercurio, ... ACS Pharmacology & Translational Science 7 (1), 259-273, 2023 | | 2023 |
| N-(3-amino-3-oxopropyl)-2-[(1-methyl-4-nitro-1h-imidazol-5-yl) thio] benzamide and its use for treating hiv infection DH Appella, H Nikolayevskiy, M Robello, MT Scerba US Patent App. 17/785,155, 2023 | | 2023 |
| Alkyl-substituted N-methylaryl-N′-aryl-4-aminobenzamides: A new series of small molecule inhibitors for Wip1 phosphatase M Robello, H Zheng, M Saha, KMG Rosenker, S Debnath, JP Kumar, ... European journal of medicinal chemistry 243, 114763, 2022 | | 2022 |
| Development of new small-molecules targeting DNA repair or purinergic system for therapeutic or diagnostic applications M Robello Università degli Studi di Pisa, 2016 | | 2016 |
| Development of novel indole-based tdp1 inhibitors for anticancer therapy M Robello, E Barresi, S Taliani, F Simorini, S Cosconati, FS Di Leva, ... 24th National Meeting On Medicinal Chemistry/Nuove Prospettive In Chimica …, 2016 | | 2016 |
| Translocator protein (tspo) ligand residence time: a new parameter to predict neurosteroidogenic efficacy for n, n-dialkyl-2-arylindol-3-ylglyoxylamides (PIGAs) S Taliani, B Costa, S Cosconati, E Barresi, E DA POZZO, A Bruno, ... 24th National Meeting On Medicinal Chemistry/Nuove Prospettive In Chimica …, 2016 | | 2016 |
| Refinement of the Mitochondrial Translocator Protein Pharmacophore/Receptor Model via Structure-activity Relationships of Novel N, N-Dialkylindolylglyoxylamides E Barresi, S Taliani, M Robello, F DA SETTIMO PASSETTI, E DA POZZO, ... 23rd National Meeting on Medicinal Chemistry/Nuove Prospettive in Chimica …, 2015 | | 2015 |
| Development of a New A2B Adenosine Receptors PET ligand: 3-Phenyl-1-[11C] methyl-3-aryl [1, 2, 4] triazino [4, 3-a] benzimidazol-4 (10H)-one M Robello, E Barresi, M Guccione, S Taliani, F DA SETTIMO PASSETTI, ... 23rd National Meeting on Medicinal Chemistry/Nuove Prospettive in Chimica …, 2015 | | 2015 |
SABRINA TALIANI確認したメール アドレス: unipi.it
